Coloplast A/s Class B · OMXCOP:COLO_B

Coloplast A/s Class B — Investor Day (2014)

14 slides from Coloplast A/s Class B's investor day presentation, 2014

  1. Slide 1: Region Emerging Markets - Growth through focus

    Region Emerging Markets - Growth through focus Coloplast Capital Market Day 2014 Kristian Villumsen, SVP Region Emerging Markets Page 1

  2. Slide 2: Introducing Region Emerging Markets

    Introducing Region Emerging Markets Region Emerging Markets Region Emerging Markets at a glance  85% of world population across 5 continents  # countries: 198 – we do business in 102 countries  # Coloplast employees: ~1,100  Sales split by Business Area products: OC 20% CC 60% 20% WSC Page 2

  3. Slide 3: The market of ~7bn DKK is fundamentally attractive - but it must be developed

    The market of ~7bn DKK is fundamentally attractive - but it must be developed Ostomy Care Continence Care Wound & Skin Care Addressable 6-8% 12-14% >10% market In billion DKK ~3 ~2 ~2 Drivers  Historical focus on Ostomy  Limited historical focus as  Increased shift from Care first reimbursement n

  4. Slide 4: Emerging Markets has been a cornerstone in the new growth strategy since 2012

    Emerging Markets has been a cornerstone in the new growth strategy since 2012 Emerging Markets share of Coloplast revenue 12/13 Emerging Markets growth ambition Emerging Markets 13% +25% Rest of Group Source: Coloplast data Page 4

  5. Slide 5: We have a strong position in the most important markets in all regions

    We have a strong position in the most important markets in all regions and thus a good starting point - Coloplast market shares in key Emerging Markets (12/13) - China Brazil Russia Argentina ~50% ~35% ~40% ~60% Source: Coloplast estimates Page 5

  6. Slide 6: We have organized ourselves in five regions

    We have organized ourselves in five regions Emerging Markets Latin America Central Eastern India, Middle-East Asia Export (Sao Paulo/Buenos Europe & Africa (Beijing) (Copenhagen) Aires) (Moscow) (Dubai) Page 6

  7. Slide 7: We believe focus is a prerequisite for growth

    We believe focus is a prerequisite for growth We have selected core growth markets We create clear roles for countries in the portfolio Core  China  Argentina Current performance growth  Brazil  Greece Foundation Growth Investment Continuous Bleeders markets Platforms Areas Improvement  Russia

  8. Slide 8: Our plan has six main strategic themes

    Our plan has six main strategic themes 1 Expand China 2  Expand Brazil 3  Turn around and then expand Russia 4  Deliver MENA 5  Sustain Greece 6  Build strong teams and commercial processes in all core and new growth markets Page 8

  9. Slide 9: Since 2012 we have invested DKK >150 mio and added more than 250 people

    Since 2012 we have invested DKK >150 mio and added more than 250 people China Brazil MENA Sales force Sales force Subsidiary expansion expansion Page 9

  10. Slide 10: We work hard to build quality into our commercial model

    We work hard to build quality into our commercial model Segmentation & Patient Targeting acquisition All core processes anchored in our new performance management Tender Key account process management management Page 10

  11. Slide 11: We are learning a lot in the process

    We are learning a lot in the process…  Getting strong, local leaders to drive our business ! Volatile and fluctuating markets  Setting minimum standards for how to run our business ! Standard of care is often underdeveloped - must be built  Working with our portfolio on a granular level ! Working

  12. Slide 12: We have been particularly pleased with the development in Brazil

    We have been particularly pleased with the development in Brazil Brazil revenue development 140 MAT index (local currency) 100 Investment launched September February 2012 2014 Source: Coloplast data Page 12

  13. Slide 13: We are pleased with the development of the overall momentum and the potential ahead of us

    We are pleased with the development of the overall momentum and the potential ahead of us Region Emerging Markets organic revenue growth Emerging Markets growth ambition In percent (as reported) 28 22 18 9 14 15 +25% Q1 Q2 Q3 Q4 Q1 Q2 12/13 12/13 12/13 12/13 13/14 13/14 Source: Coloplast earnings re

  14. Slide 14: Our mission, values and vision

    Our mission Making life easier for people with intimate healthcare needs Our values Closeness... to better understand Passion... to make a difference Respect and responsibility... to guide us Our vision Setting the global standard for listening and responding = Coloplast Page 14

Coloplast — Investor Day (2014) on 6ix